Heart failure and trimethylamine N-oxide: time to transform a 'gut feeling' in a fact?
- PMID: 36237140
- PMCID: PMC9871667
- DOI: 10.1002/ehf2.14205
Heart failure and trimethylamine N-oxide: time to transform a 'gut feeling' in a fact?
Conflict of interest statement
None.
Figures
References
-
- Krack A, Sharma R, Figulla HR, Anker SD. The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J 2005; 26: 2368–2374. - PubMed
-
- Salzano A, Cassambai S, Yazaki Y, Israr MZ, Bernieh D, Wong M, Suzuki T. The gut axis involvement in heart failure: focus on trimethylamine N‐oxide. Heart Fail Clin 2020; 16: 23–31. - PubMed
-
- Marra AM, Arcopinto M, Salzano A, Bobbio E, Milano S, Misiano G, Ferrara F, Vriz O, Napoli R, Triggiani V, Perrone‐Filardi P, Saccà F, Giallauria F, Isidori AM, Vigorito C, Bossone E, Cittadini A. Detectable interleukin‐9 plasma levels are associated with impaired cardiopulmonary functional capacity and all‐cause mortality in patients with chronic heart failure. Int J Cardiol 2016; 209: 114–117. - PubMed
-
- Tousoulis D, Guzik T, Padro T, Duncker DJ, de Luca G, Eringa E, Vavlukis M, Antonopoulos AS, Katsimichas T, Cenko E, Djordjevic‐Dikic A, Fleming I, Manfrini O, Trifunovic D, Antoniades C, Crea F. Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation. Cardiovasc Res 2022; cvac057. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical